Direct oral anticoagulants
51 results
1 - 51
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism- Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis
- Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease
- Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation
- Antifibrinolytic therapy for preventing oral bleeding in people on anticoagulants undergoing minor oral surgery or dental extractions
- Anticoagulation versus placebo for heart failure in sinus rhythm
- Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents
- Anticoagulation for the long‐term treatment of venous thromboembolism in people with cancer
- Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism
- Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery
- Antithrombotic treatment after stroke due to intracerebral haemorrhage
- Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
- Treatment for superficial thrombophlebitis of the leg
- Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia
- Computerized advice on drug dosage to improve prescribing practice: Cochrane systematic review
- Interrupted versus uninterrupted anticoagulation for cardiac rhythm management device insertion
- Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
- Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
- Interrupted versus uninterrupted anticoagulation therapy for catheter ablation in adults with arrhythmias
- Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non‐valvular atrial fibrillation
- Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery
- Pentasaccharides for the prevention of venous thromboembolism: Cochrane systematic review
- Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery
- Home versus in‐patient treatment for deep vein thrombosis
- Low molecular weight heparin for prevention of venous thromboembolism in patients with lower‐limb immobilization
- Angioplasty or stenting for deep venous thrombosis
- Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction): Cochrane systematic review
- Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery in adults: Cochrane systematic review
- Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism
- Haemostatic therapies for stroke due to acute, spontaneous intracerebral haemorrhage